General Information of Drug (ID: DMQAG1B)

Drug Name
6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one
Synonyms CHEMBL224827; 6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 253.36
Logarithm of the Partition Coefficient (xlogp) 2.3
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C13H19NO2S
IUPAC Name
2-tert-butyl-6-morpholin-4-ylthiopyran-4-one
Canonical SMILES
CC(C)(C)C1=CC(=O)C=C(S1)N2CCOCC2
InChI
InChI=1S/C13H19NO2S/c1-13(2,3)11-8-10(15)9-12(17-11)14-4-6-16-7-5-14/h8-9H,4-7H2,1-3H3
InChIKey
HCEFXOMYHGQVRM-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
16204165
TTD ID
D09YAL

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA-dependent protein kinase catalytic (PRKDC) TTK3PY9 PRKDC_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependen... J Med Chem. 2007 Apr 19;50(8):1958-72.